Xconomy San Diego

bioMérieux sa Acquires AviaraDx Inc. for $60,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3bd19d1b-f943-4afe-8bad-7931f1d58bc3&Preview=1
Date
9/11/2008
Company Name
AviaraDx Inc.
Mailing Address
11025 Roselle Street San Diego, CA 92121
Company Description
AviaraDx discovers, develops, and commercializes new molecular diagnostic tests in oncology, enabling physicians to personalize cancer treatment through better understanding of the molecular biology underlying a patient’s tumor. Our tests improve the classification of cancer, support physicians to provide their patients with a more specific prognosis or individual risk assessment, and will eventually provide information critical to predict treatment response to a given therapeutic regimen.
Website
http://www.aviaradx.com
Transaction Type
M&A
Transaction Amount
$60,000,000
Transaction Round
Proceeds Purposes
M&A Terms
French in-vitro diagnostics firm bioMerieux (BIOX.PA:) said on Thursday it bought privately held AviaraDx, Inc., based in San Diego, California for $60 million.